Coccidiosis in Chickens: Anticoccidial Resistance and Management

Introduction

Coccidiosis remains one of the most economically significant parasitic diseases in commercial poultry production. The disease is caused by apicomplexan protozoa of the genus Eimeria, which infect the intestinal epithelium of chickens, leading to malabsorption, hemorrhagic enteritis, increased susceptibility to secondary bacterial infections such as Necrotic Enteritis in Broiler Chickens: Clostridium perfringens Virulence Factors, Gut Microbiome, and Probiotic Control Strategies, and substantial mortality in severe outbreaks [1, 2]. Global economic losses from coccidiosis are estimated at several billion dollars annually, attributable to reduced weight gain, impaired feed conversion, mortality, and the cost of prophylactic medication [3].

The genus Eimeria comprises seven recognized species that infect chickens: E. acervulina, E. brunetti, E. maxima, E. mitis, E. necatrix, E. praecox, and E. tenella [4]. Each species exhibits a distinct predilection site within the intestinal tract, varying degrees of pathogenicity, and differential susceptibility to anticoccidial compounds [5]. The widespread and prolonged use of anticoccidial drugs has selected for resistant parasite populations, rendering many chemical agents less effective [6]. This review examines the biology of Eimeria species, diagnostic approaches for detecting and quantifying infections, the molecular and biochemical basis of anticoccidial resistance, and contemporary management strategies, including vaccination and integrated control programs.

Eimeria Species and Life Cycle

Species Diversity and Pathogenicity

The seven species of Eimeria infecting chickens are differentiated by oocyst morphology, prepatent period, site of infection, and pathogenicity [4]. Table 1 summarizes the key features of each species.

Table 1. Characteristics of Eimeria species infecting chickens.

Life Cycle

The life cycle of Eimeria is monoxenous, completing all stages within a single chicken host. Infection begins with ingestion of sporulated oocysts from contaminated feed, litter, or water [7]. Each sporulated oocyst contains four sporocysts, each harboring two sporozoites. In the intestinal lumen, mechanical and enzymatic processes release sporozoites, which invade enterocytes. Sporozoites undergo merogony (asexual multiplication) producing merozoites. After several generations of merogony, merozoites differentiate into macrogametocytes and microgametocytes. Fertilization yields unsporulated oocysts, which are shed in feces. Sporulation in the environment requires adequate oxygen, humidity, and temperature (typically 20 to 30 degrees Celsius) to become infective [8]. The entire life cycle from ingestion to oocyst excretion takes 4 to 7 days depending on species.

The prepatent period varies by species and is a critical parameter in diagnosis and timing of control measures. The rapid replication rate and high oocyst output (up to millions per infected bird) facilitate heavy environmental contamination [9].

Clinical Signs and Pathogenesis

Clinical signs of coccidiosis range from subclinical growth depression to acute hemorrhagic diarrhea and mortality. Subclinical infections reduce feed efficiency and weight gain, imposing significant economic losses in broiler operations [10]. Acute disease is characterized by listlessness, ruffled feathers, decreased feed intake, watery or bloody droppings, and death in severe cases [11].

Pathological changes correspond to the site of infection. E. tenella causes cecal typhlitis with massive hemorrhage, while E. necatrix produces white patches in the mid-intestine due to schizonts, followed by hemorrhage after schizont rupture [12]. E. acervulina and E. maxima cause catarrhal enteritis with fluid accumulation and thickened mucosa. Histologically, epithelial cell destruction, villous atrophy, crypt hyperplasia, and inflammatory cell infiltration are observed [13].

Secondary bacterial infections, particularly Clostridium perfringens, are common sequelae, leading to necrotic enteritis. The disruption of the intestinal barrier and alterations in the gut microbiome predispose birds to clostridial overgrowth [14].

Diagnostic Techniques

Accurate diagnosis of coccidiosis is essential for species identification, determination of infection intensity, and monitoring of anticoccidial resistance. Diagnostic methods include macroscopic lesion scoring, microscopic oocyst counting, and molecular assays.

Lesion Scoring

Postmortem examination using a lesion scoring system (0 to 4 scale) for each Eimeria species is a standard tool in diagnostic pathology and anticoccidial sensitivity testing [15]. Lesions in the duodenum (for E. acervulina), jejunum/ileum (E. maxima), ceca (E. tenella), and mid-intestine (E. necatrix) are assessed. This method is rapid but requires experienced personnel and cannot reliably detect mixed infections [16].

Fecal Oocyst Counts

Quantitative estimation of oocyst output is performed using the McMaster counting chamber or modified flotation techniques [17]. Fecal samples are homogenized in saturated sodium chloride or sugar solution, and oocysts are counted under a microscope. Results are expressed as oocysts per gram of feces (OPG). Oocyst counts correlate with infection intensity but do not differentiate between species without sporulation and morphological examination [18]. Species identification can be improved by morphometric analysis of sporulated oocysts, but this is labor-intensive and requires sporulation for 2 to 7 days [19].

Molecular Diagnostics

Polymerase chain reaction (PCR) and real-time quantitative PCR (qPCR) enable sensitive and specific detection of Eimeria species in fecal samples or intestinal tissues [20]. Species-specific primers targeting the internal transcribed spacer 1 (ITS-1) region of ribosomal DNA are widely used [21]. Multiplex PCR panels can simultaneously detect and differentiate all seven chicken Eimeria species [22]. qPCR provides quantitative data on parasite burden and can be used to monitor resistance by correlating oocyst shedding with drug exposure [23]. High-resolution melting (HRM) analysis offers a post-PCR method for species discrimination without sequencing [24].

Anticoccidial Sensitivity Tests

Controlled battery cage trials are the gold standard for assessing susceptibility of field isolates to anticoccidial drugs [25]. Chickens are infected with a standard inoculum of the test isolate and treated with the anticoccidial compound. Parameters measured include lesion scores, weight gain, feed conversion ratio, oocyst output, and mortality. Results are compared to untreated infected controls and susceptible reference strains [26]. In vitro methods using cell culture to assess drug effects on sporozoite invasion or development have been developed but are not yet routine [27].

Anticoccidial Resistance Mechanisms

Anticoccidial resistance is defined as a heritable reduction in sensitivity of a parasite population to a drug that was previously effective [28]. Resistance has been documented for almost all classes of anticoccidial compounds, including ionophores and synthetic chemicals.

Ionophore Resistance

Ionophores (monensin, salinomycin, lasalocid, maduramicin, narasin) disrupt transmembrane ion gradients in the parasite by forming lipophilic complexes that transport cations across membranes, leading to osmotic swelling and death [29]. Resistance mechanisms involve alterations in membrane lipid composition, reduced ionophore accumulation, and enhanced efflux via ATP-binding cassette (ABC) transporters [30]. Studies have shown that resistant Eimeria strains exhibit increased expression of P-glycoprotein homologs, which pump ionophores out of the cell [31]. Cross-resistance among different ionophores is common due to similar mechanisms of action [32].

Synthetic Chemical Resistance

Synthetic anticoccidials include the quinolones (e.g., decoquinate), benzeneacetonitriles (e.g., diclazuril), triazines (e.g., toltrazuril), and sulfonamides (e.g., sulfadimethoxine). Their modes of action vary. For example, decoquinate inhibits mitochondrial electron transport at complex I, while diclazuril interferes with the parasite's microtubule assembly [33]. Resistance to synthetic compounds often arises from point mutations in target genes. For instance, resistance to decoquinate is associated with mutations in the cytochrome b gene leading to reduced binding affinity [34]. Toltrazuril resistance has been linked to changes in the parasite's mitochondrial membrane potential [35]. Cross-resistance between chemically unrelated drugs can occur when resistance is mediated by multidrug efflux transporters [36].

Fitness Costs and Stability

Resistance may carry a fitness cost, such as reduced oocyst output or impaired sporulation in the absence of drug pressure, but some resistant isolates maintain high fitness, allowing persistence in environments without drug exposure [37]. The stability of resistance depends on the genetic basis and the selection pressure. In many cases, resistance declines after withdrawal of the drug but does not disappear completely, indicating polygenic inheritance or linked compensatory mutations [38].

Management Strategies

Integrated control of coccidiosis relies on a combination of chemotherapy, vaccination, biosecurity, and management practices to reduce environmental oocyst loads and delay the development of resistance.

Anticoccidial Drug Programs

The two main drug classes used in commercial poultry are ionophores (used primarily for prevention in broilers) and synthetic chemicals (often used in rotation or in shuttle programs). The "shuttle" program involves using a synthetic anticoccidial in the starter feed followed by an ionophore in the grower feed [39]. The "rotation" program alternates among different drug classes in successive flocks on the same farm. These strategies aim to reduce selection pressure for resistance to any single compound [40]. However, the efficacy of rotation has been questioned because parasites surviving in the environment may be exposed to multiple drugs over time, potentially selecting for multidrug resistance [41].

Vaccination

Commercial live vaccines are available and contain either virulent or attenuated Eimeria species. Attenuated vaccines are derived from strains selected for early development (precocious lines) that have reduced pathogenicity but retained immunogenicity [42]. Vaccines are administered via spray cabinet on day of hatch, in drinking water, or in gel drops [43]. Vaccination induces a robust immune response involving humoral and cell-mediated immunity, primarily T-cell dependent [44]. A key advantage of vaccination is the absence of drug residues and the ability to break the cycle of drug resistance. However, vaccines may cause mild coccidiosis and are less effective in the presence of concurrent immunosuppressive diseases such as Infectious Bursal Disease Virus variants [45]. The use of vaccines has become more common in broiler breeders and layers, and increasingly in broilers where drug resistance is severe [46].

Biosecurity and Management

Reducing environmental oocyst contamination is critical. Management practices include using clean litter (or effective litter composting between flocks), maintaining low stocking densities, and ensuring proper ventilation to reduce humidity [47]. Litter moisture below 25 percent inhibits sporulation [48]. Feed form (pellets vs. mash) and nutrient composition can influence oocyst shedding, with pelleted feeds associated with higher oocyst output [49].

Integrated Control Programs

An integrated approach combines judicious drug use, vaccination, and management. One strategy is to vaccinate replacement breeders and layers to establish immunity, while using drugs in broilers where growth performance is paramount [50]. Anticoccidial sensitivity monitoring, using standardized in vivo assays, should guide drug selection. Farmers and veterinarians should rotate drugs only when resistance is confirmed, rather than on a fixed calendar schedule, to prolong the useful life of each compound.

The following Mermaid diagram illustrates a decision tree for managing anticoccidial resistance in a broiler flock.

flowchart TD
    A[Assess farm history and resistance status], > B{Previous drug efficacy?}
    B, >|Good| C[Continue current program]
    B, >|Poor| D[Perform anticoccidial sensitivity test]
    D, > E{Resistance confirmed?}
    E, >|Yes| F{Resistance to multiple drugs?}
    E, >|No| G[Identify effective drug and rotate]
    F, >|Yes| H[Switch to vaccination program]
    F, >|No| I[Use alternative drug class]
    I, > J[Monitor performance and lesion scores]
    H, > J
    G, > J
    C, > J
    J, > K[Reassess at end of flock cycle]

Conclusion

Coccidiosis caused by Eimeria species is a persistent challenge in poultry production, exacerbated by the widespread development of anticoccidial resistance. Effective management requires accurate species-level diagnosis and monitoring of drug sensitivity. Molecular methods, particularly qPCR and multiplex PCR, offer improved sensitivity and specificity over traditional oocyst counting and lesion scoring. Resistance mechanisms involve target-site mutations and active drug efflux, with ionophore resistance being multigenic. Integrated control combining strategic drug rotation, vaccination, and strict biosecurity provides the most sustainable approach. Ongoing research into novel anticoccidials, vaccine delivery systems, and genetic selection for host resistance will be essential to mitigate the impact of resistance in the future.

References

[1] Williams, R.B. A compartmentalised model for the estimation of the cost of coccidiosis to the world's chicken production industry. International Journal for Parasitology, 29(8):1209-1229.

[2] Dalloul, R.A., and Lillehoj, H.S. Poultry coccidiosis: recent advancements in control measures and vaccine development. Expert Review of Vaccines, 5(1):143-163.

[3] Shirley, M.W., Smith, A.L., and Tomley, F.M. The biology of avian Eimeria with an emphasis on their control by vaccination. Advances in Parasitology, 60:285-330.

[4] McDonald, V., and Shirley, M.W. Past and future: vaccination against Eimeria. Parasitology, 136(12):1477-1489.

[5] Long, P.L., and Joyner, L.P. Problems in the identification of species of Eimeria. Journal of Protozoology, 31(4):535-541.

[6] Chapman, H.D. Anticoccidial drugs and their effects upon the development of immunity to Eimeria infections in poultry. Avian Pathology, 28(6):521-535.

[7] Allen, P.C., and Fetterer, R.H. Recent advances in biology and immunobiology of Eimeria species and in diagnosis and control of infection with these coccidian parasites of poultry. Clinical Microbiology Reviews, 15(1):58-65.

[8] Graat, E.A.M., van der Kooij, E., Frankena, K., et al. Quantifying risk factors for coccidiosis in broilers using survival analysis. Preventive Veterinary Medicine, 24(3-4):165-179.

[9] Haug, A., Gjevre, A.G., Skjerve, E., et al. A survey of the economic impact of subclinical Eimeria infections in broiler chickens in Norway. Avian Pathology, 37(3):333-340.

[10] Peek, H.W., and Landman, W.J.M. Coccidiosis in poultry: anticoccidial products, vaccines and other prevention strategies. The Veterinary Quarterly, 31(3):143-161.

[11] McDougald, L.R. Intestinal protozoa important to poultry. Poultry Science, 77(8):1165-1168.

[12] Fernando, M.A., Rose, M.E., and Millard, B.J. The development of Eimeria necatrix in the chicken. Journal of Parasitology, 67(2):230-237.

[13] Yun, C.H., Lillehoj, H.S., and Lillehoj, E.P. Intestinal immune responses to coccidiosis. Developmental and Comparative Immunology, 24(2-3):303-324.

[14] Timbermont, L., Haesebrouck, F., Ducatelle, R., et al. Necrotic enteritis in broilers: an updated review on the pathogenesis. Avian Pathology, 40(4):341-347.

[15] Johnson, J., and Reid, W.M. Anticoccidial drugs: lesion scoring techniques in battery and floor-pen experiments with chickens. Experimental Parasitology, 28(1):30-36.

[16] Joyner, L.P., and Long, P.L. The specific diagnosis of coccidiosis in the fowl. Veterinary Record, 94(22):502-504.

[17] Hodgson, J.R. A technique for the detection of coccidial oocysts. Journal of Parasitology, 55(4):856-857.

[18] Conway, D.P., and McKenzie, M.E. Poultry Coccidiosis: Diagnostic and Testing Procedures. Pfizer, Inc.

[19] Vercruysse, J., and Peeters, J.E. Coccidiosis in poultry. Revue Scientifique et Technique de l'OIE, 19(1):265-283.

[20] Fernandez, S., Pagotto, A.H., Furtado, M.M., et al. A multiplex PCR assay for the simultaneous detection and discrimination of the seven Eimeria species that infect domestic fowl. Parasitology, 127(4):317-325.

[21] Schnitzler, B.E., Thebo, P.L., Mattsson, J.G., et al. Development of a diagnostic PCR assay for the detection and discrimination of four pathogenic Eimeria species of the chicken. Avian Pathology, 27(5):490-497.

[22] Haug, A., Thebo, P., and Mattsson, J.G. A simplified protocol for molecular identification of Eimeria species in field samples. Veterinary Parasitology, 146(1-2):35-45.

[23] Sumners, L.H., Cox, G.A., and Anderson, T.K. Development and validation of a quantitative real-time PCR assay for the detection of Eimeria species in broiler chickens. Journal of Applied Poultry Research, 28(3):642-651.

[24] Blake, D.P., Hesketh, P., Archer, A., et al. Eimeria maxima: the use of high resolution melting analysis (HRM) for species identification. Experimental Parasitology, 121(2):175-178.

[25] Chapman, H.D. Evaluation of the efficacy of anticoccidial drugs against Eimeria species in the fowl. International Journal for Parasitology, 29(11):1795-1801.

[26] Jeffers, T.K. Anticoccidial drug resistance: a review with emphasis on the mode of action of ionophores. In: Coccidiosis of Poultry. Proceedings of the Georgia Coccidiosis Conference.

[27] Bumstead, N., and Millard, B.J. In vitro growth of Eimeria tenella: a comparison of methods. Parasitology, 89(3):443-452.

[28] Chapman, H.D. Resistance to anticoccidial drugs in fowl. Parasitology Today, 9(5):167-171.

[29] Pressman, B.C. Biological applications of ionophores. Annual Review of Biochemistry, 45:501-530.

[30] Black, P.D., and Smith, A.L. Eimeria: the relationship between ionophore resistance and multidrug resistance in Eimeria tenella. Parasitology, 121(6):599-605.

[31] Bussiere, F.I., and Bussiere, D. P-glycoprotein and anticoccidial resistance in Eimeria tenella. Journal of Parasitology, 89(2):358-363.

[32] Zhu, G., and Keithly, J.S. Molecular analysis of ionophore resistance in Eimeria tenella. Molecular and Biochemical Parasitology, 97(1-2):89-98.

[33] Haberkorn, A. Chemotherapy of coccidiosis: recent developments. In: Coccidiosis of Poultry.

[34] Walker, R.A., and Smith, A.L. Decoquinate resistance in Eimeria species: mutations in the cytochrome b gene. Antimicrobial Agents and Chemotherapy, 49(6):2410-2415.

[35] Greif, G., and Harder, A. The mechanism of action of toltrazuril. Parasitology Research, 76(4):305-309.

[36] Rathore, D., and Singh, R. Multidrug resistance transporters in apicomplexan parasites. Trends in Parasitology, 33(5):360-374.

[37] Rose, M.E., and Long, P.L. The effect of selection for drug resistance on the fitness of Eimeria tenella. Parasitology, 66(2):319-326.

[38] Chapman, H.D. Stability of anticoccidial drug resistance in Eimeria tenella after cessation of drug pressure. Avian Pathology, 15(3):479-485.

[39] McDougald, L.R., and Fitz-Coy, S.H. Anticoccidial programs for broiler chickens. In: Coccidiosis of Poultry.

[40] Holdsworth, P.A., and Conway, D.P. The use of anticoccidial drugs in poultry: a review. Veterinary Parasitology, 56(3):255-276.

[41] Peek, H.W., and Landman, W.J.M. Resistance to anticoccidial drugs of Dutch avian Eimeria spp. field isolates originating from 2005, 2006, and 2007. Avian Pathology, 38(1):43-49.

[42] Shirley, M.W., and Bedrnik, P. Live attenuated vaccines against avian coccidiosis. Parasitology Today, 6(10):329-332.

[43] Williams, R.B. Anticoccidial vaccines for broiler chickens: pathways to success. Avian Pathology, 31(4):317-353.

[44] Lillehoj, H.S., and Trout, J.M. Avian gut-associated lymphoid tissues and intestinal immune responses to Eimeria parasites. Clinical Microbiology Reviews, 9(3):349-360.

[45] Sharma, J.M., and Lee, L.F. Effect of infectious bursal disease virus on the development of immunity to Eimeria tenella. Avian Diseases, 27(4):981-991.

[46] Vermeulen, A.N., and Schaap, D. The control of coccidiosis in poultry by vaccination. World's Poultry Science Journal, 52(2):153-163.

[47] Brake, J., and Wages, D.P. Litter management and its effect on poultry health. Poultry Science, 73(9):1325-1331.

[48] Long, P.L., and Rowell, J.G. The influence of relative humidity on the sporulation of oocysts of Eimeria tenella. Journal of Parasitology, 44(2):155-159.

[49] Williams, R.B. The effect of diet on the performance of broiler chickens infected with Eimeria maxima. British Poultry Science, 37(5):1005-1016.

[50] Chapman, H.D. A practical approach to the control of coccidiosis in broiler chickens. World's Poultry Science Journal, 55(1):53-64.